174227-14-6 Usage
Description
BenzenesulfonaMide, N-[1,6-dihydro-5-(2-Methoxyphenoxy)-6-oxo[2,2'-bipyriMidin]-4-yl]-4-(1,1-diMethylethyl)is a complex organic compound with a unique molecular structure. It is characterized by the presence of a benzenesulfonamide group, a 1,6-dihydro-5-(2-methoxyphenoxy)-6-oxo[2,2'-bipyrimidin]-4-yl moiety, and a 1,1-dimethylethyl group. BenzenesulfonaMide, N-[1,6-dihydro-5-(2-Methoxyphenoxy)-6-oxo[2,2'-bipyriMidin]-4-yl]-4-(1,1-diMethylethyl)has potential applications in various fields due to its unique chemical properties.
Uses
Used in Pharmaceutical Industry:
BenzenesulfonaMide, N-[1,6-dihydro-5-(2-Methoxyphenoxy)-6-oxo[2,2'-bipyriMidin]-4-yl]-4-(1,1-diMethylethyl)is used as an impurity in the synthesis of Bosentan, a mixed endothelin receptor antagonist. It plays a crucial role in the development and quality control of Bosentan, ensuring the purity and efficacy of the final product.
Used as a Vasodilator and Antihypertensive:
BenzenesulfonaMide, N-[1,6-dihydro-5-(2-Methoxyphenoxy)-6-oxo[2,2'-bipyriMidin]-4-yl]-4-(1,1-diMethylethyl)is used as a vasodilator and antihypertensive agent. It helps in relaxing blood vessels, improving blood flow, and reducing blood pressure, making it a potential candidate for the treatment of hypertension and other cardiovascular diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 174227-14-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,2,2 and 7 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 174227-14:
(8*1)+(7*7)+(6*4)+(5*2)+(4*2)+(3*7)+(2*1)+(1*4)=126
126 % 10 = 6
So 174227-14-6 is a valid CAS Registry Number.
174227-14-6Relevant articles and documents
Improved Large-Scale Synthesis of Bosentan Monohydrate
Raju, K. Rajasekhara,Reddy, B. Shankar,Somannavar,Sinha,Babu, P. N. Kishore,Raju, K. Mohana
, p. 481 - 491 (2016/11/09)
-
New approaches to endothelin receptor antagonist-bosentan
Rebelli, Pradeep,Yerrabelly, Jayaprakash Rao,Yalamanchili, Bharathi Kumari,Kommera, Rajashekar,Ghojala, Venkat Reddy,Bairy, Kondal Reddy
, p. 364 - 368 (2013/07/26)
An improved and efficient synthetic process developed for an endothelin receptor antagonist, bosentan monohydrate by condensing a key intermediate 4-tert-butyl-N-(6-hydroxy-5-(2-methoxyphenoxy)-2,2'-bipyrimidine-4-yl) benezenesulfonamide 5 with commercially cheaper chloro acetonitrile and α-halo esters. This synthetic approach efficiently provides highly pure bosentan without formation of the major impurity 2 (dimer) and less than 0.15% of Nalkylated impurity 3 and pyrimidinone impurity 5 in the final product. In the present process upon purification of bosentan monohydrate gave overall yield of 62-65%.
IMPROVED PROCESS FOR THE PREPARATION OF 4-(1,1-DIMETHYLETHYL)-N-[6-(2-HYDROXYETHOXY)-5-(2-METHOXYPHENOXY)[2,2'-BIPYRIMIDIN]-4-YL]BENZENESULFONAMIDE
-
, (2011/04/13)
The present invention relates to improved process for the preparation of 4-(1,1-dimethylethyl)-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy) [2,2'-bipyrimidin]-4-yl] benzene sulfonamide monohydrate. Formula (I)